Spero Therapeutics sperotherapeutics.com


Public list: Pharma Startups (6570) Google In Healthcare (60)

Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a pipeline of antibacterials focused on unmet needs of patients with drug-resistant bacterial infections. Spero is advancing two lead programs in parallel, SPR741 and SPR994. SPR741, also called Potentiator, is a platform approach to combination therapy to treat serious and life-threatening multidrug-resistant Gram-negative infections, such as Enterobacteriaceae and Acinetobacter baumannii...Show all

Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a pipeline of antibacterials focused on unmet needs of patients with drug-resistant bacterial infections. Spero is advancing two lead programs...Show all

Company (IPO / Went public)

Phone: 857-242-1600

Fax:

675 Massachusetts Avenue
14th Floor
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Spero Therapeutics $116.9M Jun 13, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Spero Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Combination therapy to treat mycobacterium diseases Jan 19, 2017 Apr 10, 2018 Patent
Antibacterial compounds Mar 21, 2013 Mar 28, 2017 Patent
Combination therapy to treat Jul 15, 2013 Feb 21, 2017 Patent
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use Feb 06, 2018 Application
Novel tebipenem pivoxil immediate and modified release oral dosage forms Dec 15, 2017 Application